| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-0757.2005.00138.X |
| P698 | PubMed publication ID | 16398690 |
| P2093 | author name string | James D Beck | |
| Kevin Moss | |||
| Steven Offenbacher | |||
| George W Taylor | |||
| Janet H Southerland | |||
| P2860 | cites work | The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) | Q24647122 |
| NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 | ||
| Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner | Q28578147 | ||
| MyD88: an adapter that recruits IRAK to the IL-1 receptor complex | Q28611795 | ||
| The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site | Q28645645 | ||
| Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity | Q29618284 | ||
| Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis | Q33542625 | ||
| Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes | Q33752760 | ||
| Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. | Q33800716 | ||
| The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence | Q34067741 | ||
| Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis | Q40931087 | ||
| Periodontal disease as we approach the year 2000. | Q41034891 | ||
| Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein | Q41167595 | ||
| The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation | Q41280940 | ||
| Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators | Q41381486 | ||
| CD14 is a pattern recognition receptor | Q41446610 | ||
| The role of nuclear factor-kappa B in cytokine gene regulation | Q41532089 | ||
| IL-6 and APPs: anti-inflammatory and immunosuppressive mediators | Q41591668 | ||
| Rel/NF-kappa B and I kappa B proteins: an overview | Q41595423 | ||
| Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function | Q42474665 | ||
| Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake | Q42479373 | ||
| Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism. | Q42818028 | ||
| Does leptin resistance contribute to infections in patients with diabetes? | Q42937714 | ||
| Periodontal conditions in insulin-dependent diabetics | Q43569049 | ||
| Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population | Q43986425 | ||
| Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL. | Q44250487 | ||
| Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). | Q44278789 | ||
| Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease | Q44447734 | ||
| Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up | Q44653815 | ||
| Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. | Q44799753 | ||
| The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases | Q44849093 | ||
| IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts. | Q44929003 | ||
| Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells | Q45028926 | ||
| Oxidized low-density lipoproteins may induce expression of monocyte chemotactic protein-3 in atherosclerotic plaques | Q45069123 | ||
| Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes | Q45142800 | ||
| The metabolic syndrome and inflammation: association or causation? | Q45239833 | ||
| Input and Output Characteristics of Collision Avoidance Behavior in the Frog <i>Rana catesbeiana</i> | Q48164655 | ||
| Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. | Q54571368 | ||
| Periodontal pathogens in atheromatous plaques. A controlled clinical and laboratory trial. | Q54696961 | ||
| Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases | Q59084980 | ||
| Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective | Q34117734 | ||
| Oral disease, cardiovascular disease and systemic inflammation | Q34200569 | ||
| Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis | Q34200623 | ||
| Lilly Lecture 1993. Glycation and diabetic complications | Q34341917 | ||
| CHD: a major burden in type 2 diabetes | Q34519006 | ||
| The coronary circulation in diabetes: influence of reactive oxygen species on K+ channel-mediated vasodilation | Q34961815 | ||
| Microbial/host interactions: mechanisms involved in host responses to microbial antigens | Q34981933 | ||
| Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis | Q35088524 | ||
| Advanced glycoxidation. A new risk factor for cardiovascular disease? | Q35094774 | ||
| Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved? | Q35620161 | ||
| Modulation of insulin action. | Q35628619 | ||
| Lipoprotein abnormalities and their consequences for patients with type 2 diabetes | Q35675497 | ||
| Epidemiology of diabetes | Q35722893 | ||
| The AGE of the matrix: chemistry, consequence and cure | Q35771875 | ||
| Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology | Q35815962 | ||
| Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes | Q35840921 | ||
| Lipoprotein glycation and its metabolic consequences | Q35840925 | ||
| Role of cytokines in inducing hyperlipidemia | Q35840939 | ||
| Protein glycation: a firm link to endothelial cell dysfunction | Q35857303 | ||
| Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. | Q35860982 | ||
| Periodontal infections and atherosclerosis: mere associations? | Q35884667 | ||
| Molecular therapeutic targets in inflammation: cyclooxygenase and NF-kappaB. | Q35892648 | ||
| RAGE (receptor for advanced glycation end products): a central player in the inflammatory response | Q35920321 | ||
| Type 2 diabetes: epidemiologic trends, evolving pathogenetic [corrected] concepts, and recent changes in therapeutic approach | Q35977619 | ||
| Metabolic syndrome and other factors associated with increased risk of diabetes | Q36039087 | ||
| Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation | Q36355346 | ||
| Breakers of advanced glycation end products restore large artery properties in experimental diabetes. | Q36477705 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae | Q37868606 | ||
| Microbial complexes in subgingival plaque | Q38553206 | ||
| The hematopoietic activities of interleukin-1. | Q38789490 | ||
| The acute phase response | Q39387494 | ||
| The maillard or browning reaction in diabetes | Q40442553 | ||
| Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory? | Q40463310 | ||
| The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages | Q40611945 | ||
| Porphyromonas gingivalis induces murine macrophage foam cell formation | Q40622718 | ||
| Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE). | Q40829426 | ||
| The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. | Q40902436 | ||
| P921 | main subject | inflammation | Q101991 |
| periodontitis | Q520127 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 130-143 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Periodontology 2000 | Q15724648 |
| P1476 | title | Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease | |
| P478 | volume | 40 |
| Q41389439 | A population-based study on the association between the intake of soft drinks and periodontal disease in Taiwanese adults aged 35-44 years (KCIS no. 33). |
| Q24654738 | A review of the relationship between tooth loss, periodontal disease, and cancer |
| Q43720885 | Advanced glycation end products inhibit the expression of collagens type I and III by human gingival fibroblasts |
| Q51245649 | Alloxan-induced diabetes exacerbates coronary atherosclerosis and calcification in Ossabaw miniature swine with metabolic syndrome. |
| Q87732875 | An ignored cause of inflammation in patients undergoing continuous ambulatory peritoneal dialysis: periodontal problems |
| Q45243367 | Application of the theory of planned behavior to nurse practitioners' understanding of the periodontal disease-systemic link |
| Q36207146 | Association of Periodontitis With Urinary Albumin Excretion in Korean Adults With Diabetes: The 2012 Korea National Health and Nutrition Examination Survey |
| Q41291543 | Associations Among Oral Hygiene Behavior and Hypertension Prevalence and Control: The 2008 to 2010 Korea National Health and Nutrition Examination Survey |
| Q37343040 | Associations between Periodontal Microbiota and Death Rates |
| Q43519734 | Atherogenic lipoprotein parameters in patients with aggressive periodontitis |
| Q35127516 | Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature |
| Q64113795 | Chronic Inflammation as a Link between Periodontitis and Carcinogenesis |
| Q36938546 | Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. |
| Q35053820 | Diabetes and periodontitis |
| Q38667840 | Do Genetic Markers of Inflammation Modify the Relationship between Periodontitis and Nonalcoholic Fatty Liver Disease? Findings from the SHIP Study |
| Q92653661 | Effect of periodontal treatment in patients with periodontitis and diabetes: systematic review and meta-analysis |
| Q43212012 | Effect of sodium bicarbonate on Candida albicans adherence to thermally activated acrylic resin. |
| Q53562629 | Efficacy of Subgingivally Delivered 1.2% Atorvastatin in the Treatment of Chronic Periodontitis in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial. |
| Q53494909 | Essential Oil from Berries of Lebanese Juniperus excelsa M. Bieb Displays Similar Antibacterial Activity to Chlorhexidine but Higher Cytocompatibility with Human Oral Primary Cells. |
| Q79956054 | Evidence of an association between diabetes and severity of periodontal diseases |
| Q46134738 | Health care professionals' perspectives on oral care for long-term care residents: nursing staff, speech-language pathologists and dental hygienists. |
| Q45330260 | High-fiber foods reduce periodontal disease progression in men aged 65 and older: the Veterans Affairs normative aging study/Dental Longitudinal Study |
| Q34988686 | Hyper-responsive phenotype in localized aggressive periodontitis |
| Q59127235 | Improved Biocompatibility of Novel Biodegradable Scaffold Composed of Poly-L-lactic Acid and Amorphous Calcium Phosphate Nanoparticles in Porcine Coronary Artery |
| Q37226131 | Inflammatory cytokines induce a unique mineralizing phenotype in mesenchymal stem cells derived from human bone marrow |
| Q39108664 | Influence of uncontrolled diabetes mellitus on periodontal tissues during orthodontic tooth movement: a systematic review of animal studies. |
| Q43269152 | Interleukin-1 gene cluster polymorphisms associated with periodontal disease in type 2 diabetes |
| Q23918874 | Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis |
| Q26865599 | Links demystified: Periodontitis and cancer |
| Q37232614 | Mapping the pathogenesis of periodontitis: a new look |
| Q54373503 | Matrix metalloproteinase-1 of gingival fibroblasts influenced by advanced glycation end products (AGEs) and their association with receptor for AGEs and nuclear factor-κB in gingival connective tissue. |
| Q58205312 | Microbiologic Analysis of Periodontal Pockets and Carotid Atheromatous Plaques in Advanced Chronic Periodontitis Patients |
| Q88531019 | Modulation of Catalytic Promiscuity during Hydrogen Sulfide Oxidation |
| Q43199257 | Nitric oxide synthase in gingival tissues of patients with chronic periodontitis and with and without diabetes. |
| Q41870145 | Nuclear factor-kappaB p50 subunits in chronic periodontitis and Porphyromonas gingivalis lipopolysaccharide-pulsed dendritic cells |
| Q49894254 | On the analysis of complex biological supply chains: From Process Systems Engineering to Quantitative Systems Pharmacology |
| Q34038531 | Oral infectious diseases: a potential risk factor for HIV virus recrudescence? |
| Q27023976 | Periodontal Disease and Tooth Loss as Risks for Cancer: A Systematic Review of the Literature |
| Q33820183 | Periodontal disease status in gullah african americans with type 2 diabetes living in South Carolina |
| Q37108641 | Periodontal disease: associations with diabetes, glycemic control and complications |
| Q38194524 | Periodontal ligament stem cells: an update and perspectives |
| Q43467302 | Potential association of paraoxonase-1, type 2 diabetes mellitus, and periodontitis |
| Q43953751 | Progression of periodontitis and tooth loss associated with glycemic control in individuals undergoing periodontal maintenance therapy: a 5-year follow-up study |
| Q38650526 | Relationship between Type 2 Diabetic Retinopathy and Periodontal Disease in Iranian Adults |
| Q36507034 | Relationship between osteoporosis and periodontal disease: review of the literature. |
| Q34508011 | Relationship between tooth loss and carotid intima-media thickness in Korean adults |
| Q36685558 | Relationship of tooth mortality and implant treatment in Type 2 diabetes mellitus patients in Korean adults |
| Q34792463 | Risk assessment for clinical attachment loss of periodontal tissue in Korean adults. |
| Q34153135 | Serum levels of antioxidants and superoxide dismutase in periodontitis patients with diabetes type 2. |
| Q37641319 | Serum levels of inflammatory markers in type 2 diabetes patients with chronic periodontitis |
| Q33663790 | Serum zinc and magnesium concentrations in type 2 diabetes mellitus with periodontitis |
| Q46065908 | Significant association between score of periodontal disease and coronary artery disease |
| Q36688456 | Statin use is associated with fewer periodontal lesions: A retrospective study |
| Q35825064 | The activation of pyrin domain-containing-3 inflammasome depends on lipopolysaccharide from Porphyromonas gingivalis and extracellular adenosine triphosphate in cultured oral epithelial cells |
| Q48232479 | The diabetic patient and dental treatment: an update |
| Q53502069 | The influence of type I diabetes mellitus on the expression and activity of gelatinases (matrix metalloproteinases-2 and -9) in induced periodontal disease. |
| Q33634951 | Toll-like receptor 2 and type 2 diabetes |
| Q36408163 | Type 1 diabetes predisposes to enhanced gingival leukocyte margination and macromolecule extravasation in vivo |
Search more.